SCHEMBL1425513

SCHEMBL1425513

CCOC(=O)N1Cc2nc(N)nc(C=Cc3ccccc3)c2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
RAB9A P51151 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
MDM2 Q00987 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GRM4 Q14833 3/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 3/20 0.40
OPRD1 P41143 1/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
P2RX3 P56373 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
F2 P00734 3/20 0.38
F10 P00742 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1425510 1.00 ALDH1A1 (0.50) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL13495928 0.77 KDM4E (0.40) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL1424687 0.76 HSP90AA1 (0.50) ALDH1A1MAPTMAPK1NPSR1GRM4
SCHEMBL1424691 0.76 HSP90AA1 (0.50) ALDH1A1MAPTMAPK1NPSR1GRM4
SCHEMBL1425756 0.76 ALDH1A1 (0.44) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL1425480 0.75 KDM4E (0.38) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL1425313 0.75 MAPT (0.38) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL1425660 0.73 JAK2 (0.42) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL3304147 0.72 ALDH1A1 (0.46) ALDH1A1RAB9AMEN1MAPTMAPK1
SCHEMBL13361726 0.72 GRM4 (0.44) ALDH1A1RAB9AMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118111-B1 2-AMIN0-5, 7-DIHYDR0-6H- PYRROLO [3, 4-D] PYRIMIDINE DERIVATIVES AS HSP-90 INHIBITORS FOR TREATING CANCER PFIZER (US) 2011-03-23 EP disclosed
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS PFIZER INC. 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093696-A1 2-AMINO PYRIMIDINE COMPOUNDS HSP90AB2P, HSP90AB1, HSP90AA1 ALDH1A1 771/4885RAB9A 2205/4885MEN1 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.